Form 8-K - Current report:
SEC Accession No. 0001213900-14-000688
Filing Date
2014-02-07
Accepted
2014-02-07 09:38:14
Documents
3
Period of Report
2014-02-03
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k020314_actiniumpharma.htm 8-K 23094
2 CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION OF ACTINIUM PHARMACEUTICAL f8k020314ex3i_actinium.htm EX-3.1 21398
3 img1.jpg GRAPHIC 12219
  Complete submission text file 0001213900-14-000688.txt   62657
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52446 | Film No.: 14582156
SIC: 6770 Blank Checks